Product Information
INFANT PAIN-FEVER 160 MG/5 ML is a generic product labeled by Cardinal Health, priced at $0.0578 per ML under NDC 70000067401. Its NADAC has been published 74 times since May 7, 2025.
Strength
160 mg/5mL
Manufacturer
Cardinal HealthNDC
70000067401
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHENApproval Type
OTC MONOGRAPH DRUG
FDA Application
M013On Market Since
5/6/2024
Price Statistics
The NADAC for INFANT PAIN-FEVER 160 MG/5 ML has been published 74 times since May 7, 2025, and over the history we have for it it has risen 6.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0578 per ML |
|---|---|
| All-time high | $0.0592 (May 13, 2026) |
| All-time low | $0.0544 (May 7, 2025) |
| 52-week high | $0.0592 |
| 52-week low | $0.0548 |
| Median price | $0.0570 |
| Average price | $0.0568 |
| Largest weekly change | -2.0% (Aug 20, 2025) |
| Weeks tracked | 74 |
| Tracking since | May 7, 2025 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 64% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cardinal Health manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Acetaminophen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of INFANT PAIN-FEVER 160 MG/5 ML?
The current National Average Drug Acquisition Cost (NADAC) for INFANT PAIN-FEVER 160 MG/5 ML, manufactured by Cardinal Health, is $0.0578 per ML (NDC 70000067401), effective Sep 30, 2026.
How has the price of INFANT PAIN-FEVER 160 MG/5 ML changed over time?
Over the history we have for it, the NADAC for INFANT PAIN-FEVER 160 MG/5 ML has risen 6.3%. It has been tracked across 74 weekly CMS publications since May 7, 2025.
What are the highest and lowest recorded NADAC prices for INFANT PAIN-FEVER 160 MG/5 ML?
Since May 7, 2025, the NADAC for INFANT PAIN-FEVER 160 MG/5 ML has ranged from a low of $0.0544 (May 7, 2025) to a high of $0.0592 (May 13, 2026), with a median of $0.0570 per ML.
Are there cheaper alternatives to INFANT PAIN-FEVER 160 MG/5 ML?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CHILD PAIN-FEVER 160 MG/5 ML, is $0.0205 per ML — about 64% below INFANT PAIN-FEVER 160 MG/5 ML.
Who manufactures INFANT PAIN-FEVER 160 MG/5 ML?
INFANT PAIN-FEVER 160 MG/5 ML (NDC 70000067401) is labeled by Cardinal Health, and CMS classifies it as a generic product.